The Movement Toward Pharmaceutical Track and Trace

The Movement Toward Pharmaceutical Track and Trace AUGUST 30, 2017 By now, the Drug Supply Chain Security Act (DSCSA) is familiar to all U.S. pharmaceutical manufacturers. The regulation challenges the industry, requiring alterations to existing production lines and management of big data. Through the year 2023, a series of deadlines call for product and package […]

Serialization Forum Drives Collaborative Discussions, Exhibits Solutions

Pharma Serialization Forum Drives Collaboration NOVEMBER 22, 2016 The path towards compliance has many twists and turns. Presentations, discussions and live demonstrations helped forum attendees navigate this path with new pharmaceutical regulations. Mentioned before, companies in the U.S. pharmaceutical supply chain face challenges ahead. They must capture and exchange data about each pharmaceutical unit, driven by […]

Drug Industry Faces New Regulations

Drug Industry Faces New DSCSA Regulations NOVEMBER 01, 2016 Though numbers vary widely depending on country of origin, the World Health Organization estimates that between 1 and 10 percent of drugs sold around the world today are counterfeits. Additionally, around 50 percent of medicines purchased from illegal sites without a published physical address feature counterfeits. […]

Forum to Showcase Pharma Track and Trace Solutions

Forum to Showcase Pharma Track and Trace Solution OCTOBER 18, 2016 The Drug Supply Chain Security Act continues challenging all U.S. pharmaceutical manufacturers in becoming serialization and data management experts. These, and similar global regulations, demand error-free identification and tracking of products throughout the entire pharmaceutical supply chain. As a result, billions of item transactions […]